Akouos adds Dr Vicki Sato and Dr Heather Preston to Board along with raising $105m Series B financing led by Pivotal bioVenture

– USA, MA –  Akouos, Inc., a precision genetic medicine company developing potential gene therapies to restore, improve or preserve hearing, today announced it has raised $105 million in an oversubscribed Series B financing led by Pivotal bioVenture Partners, with participation from new investors Cormorant Asset Management, Cowen Healthcare Investments, EcoR1 Capital, Fidelity Management & Research Company, Polaris Founders Fund, Pagsgroup, Surveyor Capital, Wu Capital and other well-respected institutional investors.…

Dynacure announces Dr Henry Skinner to its Board along with raising €50m Series C financing led by Perceptive Advisors

– FRANCE, Strasbourg –  Dynacure, a clinical-stage drug development company focused on improving the lives of patients with rare and orphan disorders, today announced the close of a €50 million Series C financing led by Perceptive Advisors alongside new investors participating including Bpifrance Large Venture and funds managed by Tekla Capital Management LLC.…

Pandion Therapeutics adds Dr Dan Becker and Dr Chris Fuglesang to Board along with raising $80m Series B financing led by Access Biotechnology and Boxer Capital

– USA, MA –  Pandion Therapeutics, Inc., a clinical-stage, a privately-held biotechnology company developing modular protein therapeutics for autoimmune disease, today announced that it has closed an $80 million Series B financing led by Access Biotechnology and Boxer Capital and including new investors RA Capital and OrbiMed.…